Spero Therapeutics to Present Data at IDWeek 2022
CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying,...
Read moreCAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying,...
Read moreVANCOUVER, Wash., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business...
Read moreThe AWS Premier Consulting Partner is combining its AWS and cloud expertise with Datadog’s infrastructure and application monitoring capabilities to...
Read moreWARREN, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing current standards of...
Read moreAlok Saboo Wins Award for Early Career Contributions to Marketing Strategy Research Saboo, an associate professor of marketing, is the...
Read moreThe global SAN market is valued at US$ 14,921 Mn in 2014. The demand for SAN is estimated to rise...
Read moreRising demand for technologically advanced wearable with innovative features including long battery life reinforcing prospects of wrist dive computer marketWilmington,...
Read moreSinaptiStim™ – AD System provides personalized and precision-delivered electromagnetic therapeutic approach to treating cognitive and functional decline in Alzheimer’s disease...
Read moreNEW YORK and CLEVELAND, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the database lock...
Read moreHighlighting Ocugen research and innovative technologies Featuring thought leaders in gene therapy and vaccines MALVERN, Pa., Oct. 19, 2022 (GLOBE...
Read more